Cargando…
Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms
Epigenetic control of enhancers alters neuronal functions and may be involved in Alzheimer’s disease (AD). Here, we identify enhancers in neurons contributing to AD by comprehensive fine-mapping of DNA methylation at enhancers, genome-wide. We examine 1.2 million CpG and CpH sites in enhancers in pr...
Autores principales: | Li, Peipei, Marshall, Lee, Oh, Gabriel, Jakubowski, Jennifer L., Groot, Daniel, He, Yu, Wang, Ting, Petronis, Arturas, Labrie, Viviane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529540/ https://www.ncbi.nlm.nih.gov/pubmed/31113950 http://dx.doi.org/10.1038/s41467-019-10101-7 |
Ejemplares similares
-
Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis
por: Pai, Shraddha, et al.
Publicado: (2019) -
Epigenetic Biomarkers for Parkinson’s Disease: From Diagnostics to Therapeutics
por: Jakubowski, Jennifer L., et al.
Publicado: (2017) -
Transcriptional heterogeneity in the lactase gene within cell-type is linked to the epigenome
por: Oh, Edward, et al.
Publicado: (2017) -
Dysregulation of Epigenetic Mechanisms of Gene Expression in the Pathologies of Hyperhomocysteinemia
por: Perła-Kaján, Joanna, et al.
Publicado: (2019) -
Epigenetic approaches to psychiatric disorders
por: Ptak, Carolyn, et al.
Publicado: (2010)